Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Apr;3(2):138-40.
doi: 10.4103/2278-330X.130468.

Role of Crizotinib in previously treated non-small-cell lung cancer

Sunil Kumar Gupta  1
Affiliations
Case Reports

Role of Crizotinib in previously treated non-small-cell lung cancer

Sunil Kumar Gupta. South Asian J Cancer. 2014 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Baseline PET Scan of the patient showing extensive disease
Figure 2
Figure 2
PET CT before treatment with Crizotinib
Figure 3
Figure 3
PET CT after response to Crizotinib
See this image and copyright information in PMC

References

    1. A Parikh P, Puri T. Personalized medicine: Lung Cancer leads the way. Indian J Cancer. 2013;50:77–9. - PubMed
    1. Globocan 2008 data. [Last accessed on 2012 Sep 26]. Available from: http://globocan.iarc.fr/factsheet.asp .
    1. Konopa K, Jassem J. The role of pemetrexed combined with targeted agents for non-small cell lung cancer. Curr Drug Targets. 2010;11:2–11. - PubMed
    1. Reade CA, Ganti AK. EGFR targeted therapy in non-small cell lung cancer: Potential role of cetuximab. Biologics. 2009;3:215–24. - PMC - PubMed
    1. American cancer society. Detailed guide: Lung cancer - non-small cell. Non-small cell lung cancer survival rates by stage. [Last accessed on 2012 Mar 22]. Available from http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/index .

Publication types